-
61
Path analysis of factors influencing length of stay and hospitalisation expenses for oral cancer patients in tertiary hospitals in southeastern China: a cross-sectional study
Published 2025-01-01“…Aims To investigate the associations between influencing factors with length of stay (LOS) and hospitalisation expenses in oral cancer (OC) patients, and to explore the potential pathways through which these factors influence hospitalisation expenses using path analysis.Design Cross-sectional.Setting A comprehensive tertiary hospital in southeastern China.Participants A total of 810 patients with histologically confirmed primary OC admitted to the First Affiliated Hospital of Fujian Medical University, Fujian Province, between 2015 and 2020.Main outcome measures LOS and hospitalisation expenses for OC patients.Results The median hospitalisation expenses and LOS for OC patients in southeastern China were substantial, amounting to $6330 and 29 days, respectively. …”
Get full text
Article -
62
Predicting the hub interactome of COVID-19 and oral squamous cell carcinoma: uncovering ALDH-mediated Wnt/β-catenin pathway activation via salivary inflammatory proteins
Published 2025-02-01Subjects: “…Oral cancer…”
Get full text
Article -
63
-
64
Suppression of Migration and Invasion by 4-Carbomethoxyl-10-Epigyrosanoldie E from the Cultured Soft Coral Sinularia sandensis through the MAPKs Pathway on Oral Cancer Cells
Published 2024-01-01“…The ability of 4-carbomethoxyl-10-epigyrosanoldie E to inhibit the migration and invasion of Cal-27 and Ca9-22 oral cancer cells was observed to be dose dependent. …”
Get full text
Article -
65
Quercetin triggers cell apoptosis-associated ROS-mediated cell death and induces S and G2/M-phase cell cycle arrest in KON oral cancer cells
Published 2025-01-01“…Nevertheless, their antitumor efficacy against KON oral cancer is still unknown. Therefore, the aim of this investigation was to examine quercetin’s anti-growth, anti-migrative, and anti-invasive characteristics. …”
Get full text
Article -
66
Prognostic stratification of patients with AJCC 2018 pN1 disease in stage III oral squamous cell carcinoma
Published 2022-04-01Subjects: Get full text
Article -
67
Prevalence and predictive risk factor analysis of potentially malignant oral mucosal lesions among gond tribes of Bhopal
Published 2025-01-01Subjects: “…oral cancer…”
Get full text
Article -
68
The Future of Oral Oncology: How Artificial Intelligence is Redefining Surgical Procedures and Patient Management
Published 2025-02-01Subjects: Get full text
Article -
69
-
70
Hypovitaminosis D in patients with oral leukoplakia: insights from a cross-sectional study
Published 2025-02-01Subjects: Get full text
Article -
71
Malignant transformation of proliferative Verrucous Leukoplakia—systematic review & meta-analysis
Published 2025-02-01Subjects: Get full text
Article -
72
Pilot clinical trial of neoadjuvant toll-like receptor 7 agonist (Imiquimod) immunotherapy in early-stage oral squamous cell carcinoma
Published 2025-01-01Subjects: “…oral cancer…”
Get full text
Article -
73
Periodontitis promotes tumor growth and immune evasion via PD-1/PD-L1
Published 2024-11-01Subjects: Get full text
Article -
74
Expression of Cyclin D1 in Oral Squamous Cell Carcinoma
Published 2021-12-01Subjects: Get full text
Article -
75
The prognostic significance of tertiary lymphoid structures in oral squamous cell carcinomas: a systematic review
Published 2025-01-01Subjects: “…oral cancer…”
Get full text
Article -
76
CircRNF13 enhances IGF2BP1 phase separation-mediated ITGB1 mRNA stabilization in an m6A-dependent manner to promote oral cancer cisplatin chemoresistance
Published 2025-01-01Subjects: “…Oral cancer…”
Get full text
Article -
77
Prognostic significance of PD‐L2 expression in patients with oral squamous cell carcinoma—A comparison to the PD‐L1 expression profile
Published 2019-03-01Subjects: “…oral cancer…”
Get full text
Article -
78
Safety and efficacy of oral cancer vaccine B440 in patients with PD-1/PD-L1 inhibitor-resistant advanced urothelial cancer: a study protocol for a phase 1 multicenter, open-label, single-arm clinical trial
Published 2025-02-01“…Abstract Background This is a multicenter, open-label, single-arm clinical trial to evaluate the safety and efficacy of oral cancer vaccine B440 in patients with PD-1/PD-L1 inhibitor-resistant advanced urothelial cancer. …”
Get full text
Article -
79
Xception ile Histopatolojik Görüntülerden Oral Kanser Teşhisi
Published 2023-06-01Subjects: Get full text
Article -
80